How each document records it
The three sets of Saxenda® product information agree that taste changes occur, but they present them differently. The Canadian monograph gives counts because its table includes reactions down to 1%; the EU summary uses frequency bands; and the US label mentions dysgeusia only in a paragraph about early, non-digestive symptoms. [1][2][3]
| Document | Saxenda® | Placebo | What else it says |
|---|---|---|---|
| Canadian monograph, Table 3 [3] | 1.6% (53 of 3,384) | 0.8% (15 of 1,941) | Mostly mild to moderate and transient; rarely led to stopping |
| EU SmPC, Table 4 [2] | Common (≥1/100 to <1/10) | — | Leaflet: “changed sense of taste” |
| US label, section 6.1 [1] | Mentioned, no rate | — | Mainly within the first 12 weeks |
| US label, Table 3, adolescents [1] | Not listed | — | Table threshold is 3% |
The 12-week pattern
Both the US label and the Canadian monograph group dysgeusia with asthenia (weakness), fatigue, malaise and dizziness and say these were mainly reported within the first 12 weeks of treatment, often at the same time as nausea, vomiting or diarrhoea. The Canadian text adds that most were mild to moderate, did not last, and did not lead people to stop treatment. [1][3]
Those 12 weeks cover the whole dose escalation, from 0.6 mg a day in week one to 3 mg from week five, plus the first weeks on the full dose. [1] The documents do not say the taste change is caused by a particular dose step, only that reports clustered early.
What drug-safety databases show
Two analyses of the US FDA Adverse Event Reporting System looked at taste among other effects. One study of ear, nose and throat events found significant reporting signals for dysgeusia with liraglutide, as well as for hoarseness, ringing in the ears and Bell’s palsy. [4] A wider study of neurological reports across six GLP-1 medicines identified dysgeusia, taste disorder and distorted smell among 19 signals; across all neurological reports, the median time from starting treatment was 32 days. [5]
Databases like these collect suspected reactions sent in voluntarily. They show which pairings are reported more often than expected, not how often a reaction happens or whether the medicine caused it.
Possible links, from firm to uncertain
- In the label: taste changes were often co-reported with digestive reactions, which are the most frequent effects of Saxenda®; nausea affected 39% of adults on the medicine against 14% on placebo. [1]
- In the label and general medicine: dry mouth was reported by 2.3% of adults on Saxenda® against 1% on placebo, and MedlinePlus lists mouth dryness as a cause of impaired taste. [1][7]
- In research, but different: a 16-week study found that liraglutide 3 mg reduced the desire to eat sweet, salty, savoury or fatty food. [6] That is a change in food preference rather than in the sense of taste, though people may describe both as “food tastes different”.
Other causes of a changed taste
NIDCD, part of the US National Institutes of Health, notes that most people who think they have lost taste actually have a problem with smell, because flavour depends heavily on aromas reaching the nose. [8] A cold, flu, sinus infection or nasal polyps can therefore dull taste. MedlinePlus also lists gum inflammation, smoking, vitamin B12 or zinc deficiency, head injury and a range of medicines, including some antibiotics and thyroid medicines; taste also declines naturally after about 60. [7][8]
NIDCD adds that poor oral hygiene and dental problems can affect taste, and that the most common taste disorder is a lingering unpleasant taste with nothing in the mouth. [8]
What the guidance describes
MedlinePlus advises following your provider’s instructions and, for smokers, stopping smoking; taste usually returns once a cold or flu passes. [7] NIDCD stresses good oral hygiene and warns against stopping a medicine without your doctor’s advice, even if it seems to be responsible. [8] It also notes that people with impaired taste sometimes add extra sugar or salt, which matters for anyone watching blood sugar or blood pressure. [8]
If taste changes make it hard to eat normally, or combine with ongoing nausea, the Medication Guide asks you to raise side effects that bother you or do not go away with your healthcare provider. [1]
Saxenda® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Swelling of the lips, tongue or throat, or trouble breathing or swallowing | Emergency services (911 / 112) | Emergency | Medication Guide [1] |
| Metallic taste with much less urine than usual, or bruising easily | Your prescriber, the same day | Today | EU package leaflet [2]; label section 5.6 [1] |
| Nausea, vomiting or diarrhoea that does not go away, with taste changes stopping you eating or drinking | Your prescriber | Today | Medication Guide [1] |
| Taste problems that do not go away, or come with other new symptoms | Your doctor; an ear, nose and throat specialist if needed | At your next appointment | MedlinePlus [7]; NIDCD [8] |
